Cargando…
Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs
Background Antigen-detecting rapid diagnostic tests (Ag-RDT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offer new opportunities for the quick and laboratory-independent identification of infected individuals for control of the SARS-CoV-2 pandemic. Despite the potential benefits...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153114/ https://www.ncbi.nlm.nih.gov/pubmed/34068236 http://dx.doi.org/10.3390/jcm10102099 |
_version_ | 1783698729744728064 |
---|---|
author | Osmanodja, Bilgin Budde, Klemens Zickler, Daniel Naik, Marcel G. Hofmann, Jörg Gertler, Maximilian Hülso, Claudia Rössig, Heike Horn, Philipp Seybold, Joachim Lunow, Stephanie Bothmann, Melanie Barrera-Pesek, Astrid Mayrdorfer, Manuel |
author_facet | Osmanodja, Bilgin Budde, Klemens Zickler, Daniel Naik, Marcel G. Hofmann, Jörg Gertler, Maximilian Hülso, Claudia Rössig, Heike Horn, Philipp Seybold, Joachim Lunow, Stephanie Bothmann, Melanie Barrera-Pesek, Astrid Mayrdorfer, Manuel |
author_sort | Osmanodja, Bilgin |
collection | PubMed |
description | Background Antigen-detecting rapid diagnostic tests (Ag-RDT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offer new opportunities for the quick and laboratory-independent identification of infected individuals for control of the SARS-CoV-2 pandemic. Despite the potential benefits, nasopharyngeal sample collection is frequently perceived as uncomfortable by patients and requires trained healthcare personnel with protective equipment. Therefore, anterior nasal self-sampling is increasingly recognized as a valuable alternative. Methods We performed a prospective, single-center, point of care validation of an Ag-RDT using a polypropylene absorbent collector for standardized self-collected anterior nasal swabs. Real-time polymerase chain reaction (RT-PCR) from combined oropharyngeal/nasopharyngeal swabs served as a comparator. Primary endpoint was sensitivity of the standardized Ag-RDT in symptomatic patients with medium or high viral concentration (≥1 million RNA copies on RT-PCR for SARS-CoV-2). Results Between 12 February and 22 March 2021, 388 participants were enrolled. After exclusion of 9 patients for which no PCR result could be obtained, the novel Ag-RDT was evaluated based on 379 participants, of whom 273 were symptomatic and 106 asymptomatic. In 61 samples from symptomatic patients with medium or high viral load (≥1 million RNA copies), the sensitivity of the standardized Ag-RDT was 96.7% (59/61; 95% confidence interval (CI): 88.7–99.6%) for the primary endpoint. In total, 62 positive Ag-RDT results were detected out of 70 RT-PCR positive individuals, yielding an overall sensitivity of 88.6% (95% CI: 78.7–94.9%). Specificity was 99.7% (95% CI: 98.2–100%) in 309 RT-PCR negative individuals. Conclusions Here, we present a validation of a novel Ag-RDT with a standardized sampling process for anterior nasal self-collection, which meets World Health Organisation (WHO) criteria of ≥80% sensitivity and ≥97% specificity. Although less sensitive than RT-PCR, this assay could be beneficial due to its rapid results, ease of use, and suitability for standardized self-testing. |
format | Online Article Text |
id | pubmed-8153114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81531142021-05-27 Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs Osmanodja, Bilgin Budde, Klemens Zickler, Daniel Naik, Marcel G. Hofmann, Jörg Gertler, Maximilian Hülso, Claudia Rössig, Heike Horn, Philipp Seybold, Joachim Lunow, Stephanie Bothmann, Melanie Barrera-Pesek, Astrid Mayrdorfer, Manuel J Clin Med Article Background Antigen-detecting rapid diagnostic tests (Ag-RDT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offer new opportunities for the quick and laboratory-independent identification of infected individuals for control of the SARS-CoV-2 pandemic. Despite the potential benefits, nasopharyngeal sample collection is frequently perceived as uncomfortable by patients and requires trained healthcare personnel with protective equipment. Therefore, anterior nasal self-sampling is increasingly recognized as a valuable alternative. Methods We performed a prospective, single-center, point of care validation of an Ag-RDT using a polypropylene absorbent collector for standardized self-collected anterior nasal swabs. Real-time polymerase chain reaction (RT-PCR) from combined oropharyngeal/nasopharyngeal swabs served as a comparator. Primary endpoint was sensitivity of the standardized Ag-RDT in symptomatic patients with medium or high viral concentration (≥1 million RNA copies on RT-PCR for SARS-CoV-2). Results Between 12 February and 22 March 2021, 388 participants were enrolled. After exclusion of 9 patients for which no PCR result could be obtained, the novel Ag-RDT was evaluated based on 379 participants, of whom 273 were symptomatic and 106 asymptomatic. In 61 samples from symptomatic patients with medium or high viral load (≥1 million RNA copies), the sensitivity of the standardized Ag-RDT was 96.7% (59/61; 95% confidence interval (CI): 88.7–99.6%) for the primary endpoint. In total, 62 positive Ag-RDT results were detected out of 70 RT-PCR positive individuals, yielding an overall sensitivity of 88.6% (95% CI: 78.7–94.9%). Specificity was 99.7% (95% CI: 98.2–100%) in 309 RT-PCR negative individuals. Conclusions Here, we present a validation of a novel Ag-RDT with a standardized sampling process for anterior nasal self-collection, which meets World Health Organisation (WHO) criteria of ≥80% sensitivity and ≥97% specificity. Although less sensitive than RT-PCR, this assay could be beneficial due to its rapid results, ease of use, and suitability for standardized self-testing. MDPI 2021-05-13 /pmc/articles/PMC8153114/ /pubmed/34068236 http://dx.doi.org/10.3390/jcm10102099 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Osmanodja, Bilgin Budde, Klemens Zickler, Daniel Naik, Marcel G. Hofmann, Jörg Gertler, Maximilian Hülso, Claudia Rössig, Heike Horn, Philipp Seybold, Joachim Lunow, Stephanie Bothmann, Melanie Barrera-Pesek, Astrid Mayrdorfer, Manuel Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs |
title | Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs |
title_full | Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs |
title_fullStr | Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs |
title_full_unstemmed | Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs |
title_short | Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs |
title_sort | accuracy of a novel sars-cov-2 antigen-detecting rapid diagnostic test from standardized self-collected anterior nasal swabs |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153114/ https://www.ncbi.nlm.nih.gov/pubmed/34068236 http://dx.doi.org/10.3390/jcm10102099 |
work_keys_str_mv | AT osmanodjabilgin accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT buddeklemens accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT zicklerdaniel accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT naikmarcelg accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT hofmannjorg accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT gertlermaximilian accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT hulsoclaudia accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT rossigheike accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT hornphilipp accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT seyboldjoachim accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT lunowstephanie accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT bothmannmelanie accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT barrerapesekastrid accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs AT mayrdorfermanuel accuracyofanovelsarscov2antigendetectingrapiddiagnostictestfromstandardizedselfcollectedanteriornasalswabs |